Certified Global Research Member

Isomar fd.webp

Wcrc 57.webp

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players’ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Opioids Market Size, Growth and Industry Outlook By Product (Extended-Release/Long-Acting Opioid, Immediate Release/Short Acting Opioid), by Application (Pain Relief, Anesthesia, Cough Suppression, Deaddiction, Others), by End User, and by Region — Forecast till 2032.

ID: MRFR/HC/6157-CR | 110 Pages | Author: Rahul Gotadki| March 2019

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

1 Report Prologue

2 Market Introduction

2.1 Definition 17

2.2 Scope of the Study 17

2.3 Research Objective 17

2.4 Assumptions & Limitations 17

2.4.1 Assumptions 17

2.4.2 Limitations 17

2.4.3 Market Structure 18

3 Research Methodology

3.1 Primary Research Methodology 20

3.2 Secondary Research Methodology 21

3.3 Market Size Estimation 22

3.4 Forecast Model 22

4 Market Dynamics

4.1 Introduction 24

4.2 Drivers 25

4.2.1 Increasing use of opioids for disease condition causing chronic pains such as cancers, arthritis, lower back pain, and fibromyalgia 25

4.2.2 Favorable reimbursement policies for palliative care in developed regions 25

4.2.3 Substantial rise in road accidents, trauma, and surgical procedures 25

4.3 Restraints 26

4.3.1 Rising addiction and death cases due to overdose of opioid 26

4.4 Opportunities 26

4.4.1 Reconsideration of prescribing opioid analgesics due to rising awareness about opioids misuse, abuse, and overdose has prompted many stakeholders 26

5 Market Factor Analysis

5.1 Porter’s Five Forces Model 28

5.1.1 Bargaining Power of Suppliers 28

5.1.2 Bargaining Power of Buyers 29

5.1.3 Threat of New Entrants 29

5.1.4 Threat of Substitutes 29

5.1.5 Intensity of Rivalry 29

5.2 Value Chain Analysis 30

5.2.1 Research &Development 30

5.2.2 Manufacturing 30

5.2.3 Distribution 30

5.2.4 Marketing & Sales 31

5.2.5 Post-Sales Monitoring 31

5.3 Demand & Supply: Gap Analysis 31

5.4 Pricing Analysis 31

6 Opioids Market, by Product

6.1 Overview 33

6.2 Extended-Release/Long-Acting Opioid 34

6.3 Immediate-Release/Short-Acting Opioid 36

7 Opioids Market, by Application

7.1 Overview 39

7.2 Pain Relief 40

7.3 Anesthesia 41

7.4 Cough Suppression 42

7.5 Diarrhoea Suppression 43

7.6 Deaddiction 43

8 Opioids Market, by End User

8.1 Overview 45

8.2 Hospitals & Clinics 46

8.3 Pharmacies 47

8.4 Academic Research Institutes 47

9 Global Opioids Market, by Region

9.1 Overview 50

9.2 Americas 51

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.2.1 North America 55

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.2.2 US 58

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.2.3 Canada 61

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.2.4 Latin America 64

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3 Europe 68

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3.1 Western Europe 72

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3.2 Germany 76

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3.3 UK 79

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3.4 France 82

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3.5 Spain 85

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3.6 Italy 88

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3.7 Rest of Western Europe 91

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.3.8 Eastern Europe 94

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.4 Asia-Pacific 97

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.4.1 China 101

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.4.2 Japan 104

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.4.3 India 107

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.4.4 Australia 110

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.4.5 South Korea 113

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.4.6 Rest of Asia-Pacific 116

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.5 Middle East & Africa 120

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.5.1 Middle East 124

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

9.5.2 Africa 127

Opioids Market, by Product

Opioids Market, by Application

Opioids Market, by End User

10 Competitive Landscape

10.1 Company Market Share Analysis 131

10.1.1 Overview 131

11 Company Profile

11.1 Sanofi SA 133

11.1.1 Company Overview 133

11.1.2 Financial Overview 133

11.1.3 Products/Services Offered 133

11.1.4 Key Developments 134

11.1.5 SWOT Analysis 134

11.1.6 Key Strategy 134

11.2 Pfizer Inc 135

11.2.1 Company Overview 135

11.2.2 Financial Overview 135

11.2.3 Products/Services Offered 136

11.2.4 Key Developments 136

11.2.5 SWOT Analysis 136

11.2.6 Key Strategy 136

11.3 Boehringer Ingelheim GmbH 137

11.3.1 Company Overview 137

11.3.2 Financial Overview 137

11.3.3 Products/Services Offered 137

11.3.4 Key Developments 138

11.3.5 SWOT Analysis 138

11.3.6 Key Strategy 138

11.4 Teva Pharmaceutical Industries Ltd 139

11.4.1 Company Overview 139

11.4.2 Financial Overview 139

11.4.3 Products/Services Offered 140

11.4.4 Key Developments 140

11.4.5 SWOT Analysis 141

11.4.6 Key Strategy 141

11.5 Allergan Inc. 142

11.5.1 Company Overview 142

11.5.2 Financial Overview 142

11.5.3 Products/Services Offered 143

11.5.4 SWOT Analysis 143

11.5.5 Key Developments 143

11.5.6 Key strategy 143

11.6 Purdue Pharma L.P. 144

11.6.1 Company Overview 144

11.6.2 Financial Overview 144

11.6.3 Products/Services Offered 144

11.6.4 Key Developments 144

11.6.5 SWOT Analysis 145

11.6.6 Key Strategy 145

11.7 West-Ward Pharmaceuticals Corporation 146

11.7.1 Company Overview 146

11.7.2 Financial Overview 146

11.7.3 Products/Services Offered 146

11.7.4 Key Developments 147

11.7.5 SWOT Analysis 147

11.7.6 Key Strategy 147

11.8 Sun Pharmaceutical Industries Ltd 148

11.8.1 Company Overview 148

11.8.2 Financial Overview 148

11.8.3 Products/Services Offered 149

11.8.4 Key Developments 149

11.8.5 SWOT Analysis 149

11.8.6 Key Strategy 149

11.9 Egalet Corporation 150

11.9.1 Company Overview 150

11.9.2 Financial Overview 150

11.9.3 Products/Services Offered 150

11.9.4 Key Developments 150

11.9.5 SWOT Analysis 150

11.9.6 Key Strategy 150

11.10 Janssen Global Services, LLC 151

11.10.1 Company Overview 151

11.10.2 Financial Overview 151

11.10.3 Products/Services Offered 152

11.10.4 Key Developments 152

11.10.5 SWOT Analysis 152

11.10.6 Key Strategy 152

11.11 Vertice Pharma LLC 153

11.11.1 Company Overview 153

11.11.2 Financial Overview 153

11.11.3 Products/Services Offered 153

11.11.4 Key Developments 153

11.11.5 SWOT Analysis 153

11.11.6 Key Strategy 153

11.12 Mallinckrodt 154

11.12.1 Company Overview 154

11.12.2 Financial Overview 154

11.12.3 Products/Services Offered 154

11.12.4 Key Developments 155

11.12.5 SWOT Analysis 155

11.12.6 Key Strategy 155

12 Appendix

12.1 Discussion Blue Print 157

13 List of Tables

TABLE 1 MARKET SYNOPSIS 14

TABLE 2 PRIMARY INTERVIEWS 21

TABLE 3 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 33

TABLE 4 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY REGION, 2020–2027 (USD MILLION) 34

TABLE 5 GLOBAL OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 35

TABLE 6 GLOBAL OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY REGION, 2020–2027 (USD MILLION) 36

TABLE 7 GLOBAL OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 37

TABLE 8 GLOBAL OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 39

TABLE 9 GLOBAL OPIOIDS MARKET FOR PAIN RELIEF, BY REGION, 2020–2027 (USD MILLION) 40

TABLE 10 GLOBAL OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 41

TABLE 11 GLOBAL OPIOIDS MARKET FOR ANESTHESIA, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 12 GLOBAL OPIOIDS MARKET FOR COUGH SUPPRESSION, BY REGION, 2020–2027 (USD MILLION) 42

TABLE 13 GLOBAL OPIOIDS MARKET FOR DIARRHOEA SUPPRESSION, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 14 GLOBAL OPIOIDS MARKET FOR DEADDICTION, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 15 GLOBAL OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 45

TABLE 16 GLOBAL OPIOIDS MARKET FOR HOSPITALS & CLINICS, BY REGION, (USD MILLION) 46

TABLE 17 GLOBAL OPIOIDS MARKET FOR PHARMACIES, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 18 GLOBAL OPIOIDS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 19 GLOBAL OPIOIDS MARKET, BY REGION, 2020–2027 (USD MILLION) 50

TABLE 20 AMERICAS: OPIOIDS MARKET, BY REGION, 2020–2027 (USD MILLION) 51

TABLE 21 AMERICAS: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 52

TABLE 22 AMERICAS: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 52

TABLE 23 AMERICAS: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 53

TABLE 24 AMERICAS: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 53

TABLE 25 AMERICAS: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 54

TABLE 26 AMERICAS: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 54

TABLE 27 NORTH AMERICA: OPIOIDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 55

TABLE 28 NORTH AMERICA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 55

TABLE 29 NORTH AMERICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 30 NORTH AMERICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 56

TABLE 31 NORTH AMERICA: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 57

TABLE 32 NORTH AMERICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 33 NORTH AMERICA: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 58

TABLE 34 US: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 58

TABLE 35 US: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 36 US: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 59

TABLE 37 US: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 60

TABLE 38 US: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 39 US: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 61

TABLE 40 CANADA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 61

TABLE 41 CANADA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 42 CANADA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 62

TABLE 43 CANADA: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 63

TABLE 44 CANADA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 45 CANADA: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 64

TABLE 46 LATIN AMERICA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 64

TABLE 47 LATIN AMERICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 48 LATIN AMERICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 49 LATIN AMERICA: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 66

TABLE 50 LATIN AMERICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 66

TABLE 51 LATIN AMERICA: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 67

TABLE 52 EUROPE: OPIOIDS MARKET, BY REGION, 2020–2027 (USD MILLION) 68

TABLE 53 EUROPE: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 69

TABLE 54 EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 69

TABLE 55 EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 70

TABLE 56 EUROPE: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 70

TABLE 57 EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 71

TABLE 58 EUROPE: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 71

TABLE 59 WESTERN EUROPE: OPIOIDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72

TABLE 60 WESTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 73

TABLE 61 WESTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 73

TABLE 62 WESTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 74

TABLE 63 WESTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 74

TABLE 64 WESTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 65 WESTERN EUROPE: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 75

TABLE 66 GERMANY: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 76

TABLE 67 GERMANY: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 76

TABLE 68 GERMANY: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 69 GERMANY: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77

TABLE 70 GERMANY: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 78

TABLE 71 GERMANY: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 78

TABLE 72 UK: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 79

TABLE 73 UK: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 74 UK: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 80

TABLE 75 UK: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 80

TABLE 76 UK: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 77 UK: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 81

TABLE 78 FRANCE: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 82

TABLE 79 FRANCE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 82

TABLE 80 FRANCE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 81 FRANCE: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 83

TABLE 82 FRANCE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 84

TABLE 83 FRANCE: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 84

TABLE 84 SPAIN: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 85

TABLE 85 SPAIN: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 86 SPAIN: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 86

TABLE 87 SPAIN: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86

TABLE 88 SPAIN: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 89 SPAIN: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 87

TABLE 90 ITALY: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 88

TABLE 91 ITALY: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 88

TABLE 92 ITALY: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 93 ITALY: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89

TABLE 94 ITALY: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 90

TABLE 95 ITALY: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 90

TABLE 96 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 91

TABLE 97 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 91

TABLE 98 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 92

TABLE 99 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 92

TABLE 100 REST OF WESTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 101 REST OF WESTERN EUROPE: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 93

TABLE 102 EASTERN EUROPE: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 94

TABLE 103 EASTERN EUROPE: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 94

TABLE 104 EASTERN EUROPE: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 105 EASTERN EUROPE: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 95

TABLE 106 EASTERN EUROPE: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 96

TABLE 107 EASTERN EUROPE: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 96

TABLE 108 ASIA-PACIFIC: OPIOIDS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98

TABLE 109 ASIA-PACIFIC: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 98

TABLE 110 ASIA-PACIFIC: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 111 ASIA-PACIFIC: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 112 ASIA-PACIFIC: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 100

TABLE 113 ASIA-PACIFIC: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 100

TABLE 114 ASIA-PACIFIC: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 101

TABLE 115 CHINA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 101

TABLE 116 CHINA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 117 CHINA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 102

TABLE 118 CHINA: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103

TABLE 119 CHINA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 120 CHINA: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 104

TABLE 121 JAPAN: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 104

TABLE 122 JAPAN: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 123 JAPAN: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 124 JAPAN: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 106

TABLE 125 JAPAN: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 106

TABLE 126 JAPAN: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 107

TABLE 127 INDIA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 107

TABLE 128 INDIA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 129 INDIA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 108

TABLE 130 INDIA: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 109

TABLE 131 INDIA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 132 INDIA: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 110

TABLE 133 AUSTRALIA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 110

TABLE 134 AUSTRALIA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 135 AUSTRALIA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 136 AUSTRALIA: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 112

TABLE 137 AUSTRALIA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 112

TABLE 138 AUSTRALIA: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 113

TABLE 139 SOUTH KOREA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 113

TABLE 140 SOUTH KOREA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 141 SOUTH KOREA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 114

TABLE 142 SOUTH KOREA: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 115

TABLE 143 SOUTH KOREA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 115

TABLE 144 SOUTH KOREA: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 116

TABLE 145 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 116

TABLE 146 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 117

TABLE 147 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 117

TABLE 148 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 118

TABLE 149 REST OF ASIA-PACIFIC: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 118

TABLE 150 REST OF ASIA-PACIFIC: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 119

TABLE 151 MIDDLE EAST & AFRICA: OPIOIDS MARKET, BY REGION, 2020–2027 (USD MILLION) 120

TABLE 152 MIDDLE EAST & AFRICA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 121

TABLE 153 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 121

TABLE 154 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 122

TABLE 155 MIDDLE EAST & AFRICA : OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 122

TABLE 156 MIDDLE EAST & AFRICA : OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 123

TABLE 157 MIDDLE EAST & AFRICA : OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 123

TABLE 158 MIDDLE EAST: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124

TABLE 159 MIDDLE EAST: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 124

TABLE 160 MIDDLE EAST: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 125

TABLE 161 MIDDLE EAST: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125

TABLE 162 MIDDLE EAST: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 126

TABLE 163 MIDDLE EAST: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 126

TABLE 164 AFRICA: OPIOIDS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127

TABLE 165 AFRICA: OPIOIDS MARKET FOR EXTENDED-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 127

TABLE 166 AFRICA: OPIOIDS MARKET FOR IMMEDIATE-RELEASE OPIOID, BY TYPE, 2020–2027 (USD MILLION) 128

TABLE 167 AFRICA: OPIOIDS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128

TABLE 168 AFRICA: OPIOIDS MARKET FOR PAIN RELIEF, BY TYPE, 2020–2027 (USD MILLION) 129

TABLE 169 AFRICA: OPIOIDS MARKET, BY END USER, 2020–2027 (USD MILLION) 129

14 List of Figures

FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES 22

FIGURE 2 MARKET DYNAMICS: GLOBAL OPIOIDS MARKET 24

FIGURE 3 PORTER’S FIVE FORCES ANALYSIS: GLOBAL OPIOIDS MARKET 28

FIGURE 4 SUPPLY CHAIN: OPIOIDS MARKET 30

FIGURE 5 GLOBAL OPIOIDS MARKET, BY PRODUCT, 2020 & 2027 (USD MILLION) 33

FIGURE 6 GLOBAL OPIOIDS MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 39

FIGURE 7 GLOBAL OPIOIDS MARKET, BY END USER, 2020 & 2027 (USD MILLION) 45

FIGURE 8 GLOBAL OPIOIDS MARKET, BY REGION, 2020 & 2027 (USD MILLION) 50

FIGURE 9 AMERICAS: OPIOIDS MARKET SHARE, BY REGION, 2020 (%) 51

FIGURE 10 NORTH AMERICA: OPIOIDS MARKET SHARE, BY COUNTRY, 2020 (%) 55

FIGURE 11 EUROPE: OPIOIDS MARKET SHARE, BY REGION, 2020 (%) 68

FIGURE 12 WESTERN EUROPE: OPIOIDS MARKET SHARE, BY COUNTRY, 2020 (%) 72

FIGURE 13 ASIA-PACIFIC: OPIOIDS MARKET SHARE, BY COUNTRY, 2020 (%) 97

FIGURE 14 MIDDLE EAST & AFRICA: OPIOIDS MARKET SHARE, BY REGION, 2020 (%) 120

FIGURE 15 GLOBAL OPIOIDS MARKET SHARE ANALYSIS, 2020 (%) 131

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

Related Reports

Painkiller Market Research Report — Global Forecast till 2032

Post-operative Pain Management Market Research Report - Forecast to 2032

Veterinary Pain Management Market Research Report - Global Forecast till 2032

Pain Relief Medication Market Research Report - Forecast till 2032

Press Release

Opioids Market Size To Expand at a Notable CAGR Of 4.90% During 2022 - 2030

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)